| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-01 | Peetz Christopher | director, officer | Option exercise | 30,000 | $2.94 | $88K |
| 2026-06-01 | Ramasastry Saira | director | Sale | 3,977 | $100.00 | $398K |
| 2026-05-29 | Walbert Timothy P | director | Option exercise | 3,977 | — | — |
| 2026-05-29 | Cardon Lon | director | Option exercise | 3,977 | — | — |
| 2026-05-29 | Ramasastry Saira | director | Option exercise | 3,977 | — | — |
| Filed | Form | Filer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-01-27 | SCHEDULE | Frazier Life Sciences IX, L.P. | 6.80% | 4,108,404 | view → |
| 2023-09-05 | SC | Frazier Life Sciences IX, L.P. | — | — | view → |
| 2022-08-18 | SC | Novo Holdings A/S | — | — | view → |
| 2020-12-22 | SC | RiverVest Venture Fund IV, L.P. | — | — | view → |
| 2020-12-18 | SC | Frazier Life Sciences IX, L.P. | — | — | view → |
| 2020-12-18 | SC | Novo Holdings A/S | — | — | view → |
| 2020-01-17 | SC | Novo Holdings A/S | — | — | view → |
| Filed | Form | Issuer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-01-27 | SCHEDULE | Mirum Pharmaceuticals, Inc. MIRM | 6.80% | 4,108,404 | view → |
| 2023-09-05 | SC | Mirum Pharmaceuticals, Inc. MIRM | — | — | view → |
| 2022-09-26 | SC | Phathom Pharmaceuticals, Inc. PHAT | — | — | view → |
| 2021-01-27 | SC | Passage BIO, Inc. PASG | — | — | view → |
| 2020-12-18 | SC | Mirum Pharmaceuticals, Inc. MIRM | — | — | view → |
Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.
See pricing →